Diffuse Midline Glioma — Trials

Diffuse Midline Glioma — Trials · CancerIndex

Clinical trials

Registered studies

129 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 61
Recruiting: 32
Ph III recruiting: 1
Growth YoY: —
Industry share: 18%
Top sponsor: Nationwide Children's Hospital
Termination share: 43.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05063357	131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma	withdrawn	Phase 1	0	Y-mAbs TherapeuticsINDUSTRY	0	Jun 26, 2023	clinicaltrials
NCT04051047	Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma	withdrawn	Early Phase 1	0	University of Michigan Rogel Cancer CenterOTHER	1	Nov 27, 2019	clinicaltrials